Abstract
This study was to investigate the synthesis and biological evaluation of [99mTc]Tc-labeled Buthus martensii Karsch Chlorotoxin ([99mTc]Tc-BmK CT) as a radiopharmaceutical for glioma single photon computed emission tomography (SPECT) imaging. The results showed that BmK CT peptide modified with a hexahistidine tag displayed good cytocompatibility in vitro, and could be efficiently radiolabeled with 99mTc via [99mTc]Tc-tricarbonyl chemistry. The [99mTc]Tc-BmK CT showed satisfactory radiochemical purity and stability in vitro, and could be developed as a probe for targeted SPECT imaging of glioma cells in vitro and in a tumor-bearing mouse model. Our data indicated that the synthesized [99mTc]Tc-BmK CT might be developed as a promising imaging agent for glioma diagnostic application.
Similar content being viewed by others
References
Lim M, Xia Y, Bettegowda C, Weller M (2018) Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol 15(7):422–442
Bush NAO, Chang SM, Berger MS (2017) Current and future strategies for treatment of glioma. Neurosurg Rev 40(1):1–14
Chen R, Cohen AL, Colman H (2016) Targeted therapeutics in patients with high-grade gliomas: past, present, and future. Curr Treat Options Oncol 17(8):42
Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R, Reifenberger G (2015) Glioma. Nat Rev Dis Primers 1(1):15017
Cohen G, Burks SR, Frank JA (2018) Chlorotoxin—a multimodal imaging platform for targeting glioma tumors. Toxins 10(12):496
Parrish-Novak J, Byrnes-Blake K, Lalayeva N, Burleson S, Fidel J, Gilmore R, Gayheart-Walsten P, Bricker GA, Crumb WJ, Tarlo KS, Hansen S, Wiss V, Malta E, Dernell WS, Olson JM, Miller DM (2017) Nonclinical profile of BLZ-100, a tumor-targeting fluorescent imaging agent. Int J Toxicol 36(2):104–112
Qiao W, Zhao L, Wu S, Liu C, Guo L, Xing Y, Zhao J (2017) SPECT imaging and radionuclide therapy of glioma using 131I labeled Buthus martensii Karsch chlorotoxin. J Neurooncol 133(2):287–295
Hockaday DC, Shen S, Fiveash J, Raubitschek A, Colcher D, Liu A, Alvarez V, Mamelak AN (2005) Imaging glioma extent with 131I-TM-601. J Nucl Med 46(4):580–586
Mamelak AN, Rosenfeld S, Bucholz R, Raubitschek A, Nabors LB, Fiveash JB, Shen S, Khazaeli MB, Colcher D, Liu A, Osman M, Guthrie B, Schade-Bijur S, Hablitz DM, Alvarez VL, Gonda MA (2006) Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol 24(22):3644–3650
Shen S, Khazaeli MB, Gillespie G, Alvarez VL (2003) Radiation dosimetry of I-131-TM-601 peptide for synergistic targeted radiotherapy for malignant glioma in mice. J Neurooncol 71(2):113–119
Fu Y, An N, Chan K, Wu Y, Zheng S, Liang A (2011) A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study. Biotechnol Lett 33(7):1309–1317
Lin X, Ruan Q, Lin L, Zhang X, Duan X, Teng Y, Zhang J (2018) Biological evaluation and SPECT imaging of tumor hypoxia using a novel technetium-99m labeled tracer with 2-nitroimidazole moiety. J Radioanal Nucl Chem 317(3):1463–1468
De Saint-Hubert M, Mottaghy FM, Vunckx K, Nuyts J, Fonge H, Prinsen K, Stroobants S, Mortelmans L, Deckers N, Hofstra L, Reutelingsperger CPM, Verbruggen A, Rattat D (2010) Site-specific labeling of ‘second generation’ annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo. Bioorg Med Chem 18(3):1356–1363
Carpenet H, Cuvillier A, Monteil J, Quelven I (2015) Anti-CD20 immunoglobulin G radiolabeling with a 99mTc-tricarbonyl core: in vitro and in vivo evaluations. PLoS ONE 10(10):e0139835
Zhang X, Teixeira V, Porcal W, Cabral P, Gambini J-P, Fernandez M, Gallazzi F, Quinn P T (2014) [99mTc(CO)3]+ and [99mTcO2]+ Radiolabeled cyclic melanotropin peptides for melanoma SPECT imaging. Curr Radiopharm 7(1):63–74
Xing Y, Chand G, Liu C, Cook GJR, O’Doherty J, Zhao L, Wong NCL, Meszaros LK, Ting HH, Zhao J (2019) Early phase I study of a 99mTc-labeled anti-programmed death ligand-1 (PD-L1) single-domain antibody in SPECT/CT assessment of PD-L1 expression in non-small cell lung cancer. J Nucl Med 60(9):1213–1220
Wu S, Ma K, Qiao W, Zhao L, Liu C, Guo L, Xing Y, Zhu M, Zhao J (2018) Anti-metastatic effect of 131I-labeled Buthus martensii Karsch chlorotoxin in gliomas. Int J Mol Med 42(6):3386–3394
Du J, Fu Y, Wang J, Liang A (2013) Adenovirus-mediated expression of BmK CT suppresses growth and invasion of rat C6 glioma cells. Biotechnol Lett 35(6):861–870
Sun N, Zhao L, Qiao W, Xing Y, Zhao J (2017) BmK CT and 125I-BmK CT suppress the invasion of glioma cells in vitro via matrix metalloproteinase-2. Mol Med Rep 15(5):2703–2708
Banks WA (2016) From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15(4):275–292
Veiseh O, Gunn JW, Kievit FM, Sun C, Fang C, Lee JS, Zhang M (2009) Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 5(2):256–264
Acknowledgements
The work was financially supported by the National Natural Science Foundation of China (81671712 and 81801727), and the Ningxia Key Research and Development Program (2019BEG03018).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liu, C., Wang, T., Zhao, L. et al. Biological evaluation of [99mTc]Tc-labeled Buthus martensii Karsch Chlorotoxin peptide for glioma imaging. J Radioanal Nucl Chem 326, 193–199 (2020). https://doi.org/10.1007/s10967-020-07293-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-020-07293-4